Darden Wealth Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$657K Buy
2,588
+341
+15% +$79.5K 0.26% 79
2026
Q1
$549K Sell
2,247
-100
-4% -$23.3K 0.28% 79
2025
Q4
$486K Hold
2,347
0.24% 81
2025
Q3
$435K Buy
2,347
+41
+2% +$7.02K 0.23% 88
2025
Q2
$352K Sell
2,306
-596
-21% -$91.6K 0.21% 95
2025
Q1
$481K Sell
2,902
-35
-1% -$5.48K 0.37% 60
2024
Q4
$425K Sell
2,937
-94
-3% -$14.6K 0.29% 67
2024
Q3
$491K Sell
3,031
-45
-1% -$7.17K 0.35% 61
2024
Q2
$450K Sell
3,076
-878
-22% -$131K 0.27% 61
2024
Q1
$626K Sell
3,954
-709
-15% -$113K 0.49% 58
2023
Q4
$731K Buy
+4,663
New +$715K 0.7% 40

Other funds holding JNJ

Darden Wealth Group's JNJ Position: Q2 2026 in Review

Darden Wealth Group increased its Johnson & Johnson (JNJ) stake by 15% in Q2 2026, buying an estimated $79.5K and bringing the position to 2,588 shares worth $657K. The position accounts for 0.26% of the portfolio, ranked #79.

Darden Wealth Group first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $731K in Q4 2023. 4,686 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Darden Wealth Group held 2,588 shares of Johnson & Johnson worth $657K as of Q2 2026.
  • Darden Wealth Group bought 341 Johnson & Johnson shares in Q2 2026, an estimated $79.5K.
  • Johnson & Johnson made up 0.26% of Darden Wealth Group's portfolio in Q2 2026, its #79 holding.
  • Darden Wealth Group first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • Darden Wealth Group's Johnson & Johnson position peaked at $731K in Q4 2023.
  • 4,686 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Darden Wealth Group's 13F filing for Q2 2026, filed 6 Aug 2026.